Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients
Clinical trial NCT05002140 · COMPLETED
Trial details
- NCT number
- NCT05002140
- Sponsor
- XRad Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2023-07-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.